Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Get Free Report) in a research note issued on Wednesday. The firm set a “buy” rating on the health services provider’s stock. Amedisys Stock Performance NASDAQ AMED opened at $93.02 on Wednesday. The stock has a 50-day simple moving average of $94.29 and […]
Gotham Asset Management LLC increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 6.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,536 shares of the health services provider’s stock after buying an additional 4,430 shares during the […]
Pentwater Capital Management LP grew its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 239.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,144,000 shares of the health services provider’s stock after buying an additional 807,000 shares […]
AQR Arbitrage LLC boosted its stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 407.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 314,321 shares of the health services provider’s stock after acquiring an additional 252,405 shares during the period. […]
Gotham Asset Management LLC raised its holdings in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 6.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 75,536 shares of the health services provider’s stock after acquiring an additional 4,430 shares during the quarter. […]